Virginia Senate Panel Rejects Contribution Limits, but Other Reforms Will Be Considered
Virginia's notoriously lax ethics and campaign finance laws are the targets of a slew of bipartisan reform bills scheduled for hearings in the weeks ahead.
Virginia's notoriously lax ethics and campaign finance laws are the targets of a slew of bipartisan reform bills scheduled for hearings in the weeks ahead.
The Business Roundtable increased its lobbying spending last year by 70% over the previous year as its members pushed to pass the infrastructure bill first and kill the Build Back Better Act.
Rearden represented Chevron in its case against environmental and human rights attorney Steven Donziger, according to reports.
Executives at well-connected corporate consultancies voted to approve DNC Chair Jaime Harrison's slate of "at-large" members, which included several new corporate lobbyists.
The companies' donations appear to contradict their public statements in support of voting rights.
While Congress considered infrastructure and climate legislation last year, reps kept up a stream of trades in oil and gas pipeline company stocks.
Sen. Jon Ossoff (D-GA) is planning a bill to ban stock trading by federal lawmakers and their spouses, but it faces an uphill battle this year.
Many Hill lobbyists opted not to follow their employers' PAC policy and donated to the 147 Republican election objectors in Congress.
Four Republicans with extensive ties to the pharmaceutical industry have already said they plan to cross the aisle and support Califf's confirmation to be commissioner of the Food and Drug Administration.
The most-cosponsored bill to ban stock trading while in office leaves a huge loophole for trading corporate stocks based on nonpublic information.